Device Trial Radar · NCT03365154
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat Peripheral Artery Disease (PAD)
Last checked: Nov 20, 2026Latest source record: May 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jan 25, 2018
Primary completion
Feb 22, 2018
Study completion Nov 6, 2018
Sponsor
- Lead sponsor
- Cardio Flow, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Libra Medical
- First posted
- Dec 7, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a First in Human early feasibility study of a novel atherectomy device to treat peripheral artery disease. The trial is a prospective, single arm design that will enroll 10 patients at 1 - 2 sites. Patients will be followed at 30 days and 6 months to evaluate vessel patency following treatment. Safety will be assessed by monitoring adverse events throughout the study. Safety and Efficacy will be evaluated by comparing study results to established performance criteria,
Conditions
- Peripheral Arterial Disease
Interventions
Cardio Flow FreedomFlow™ Orbital Atherectomy System treatmentDevice
Occlusive lesions will be treated using atherectomy with or without adjunctive low pressure balloon angioplasty.
Balloon AngioplastyDevice
Low pressure balloon angioplasty may be used following atherectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Treated Lesions With Achievement of ≤ 50% Residual Stenosis Without Adjunctive TherapyTime frame: At time of procedure
- Number of Participants Who Were Free From New-onset Major Adverse Events at 30 Days Post-treatmentTime frame: 30 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Cardiovascular Research of North Florida, LLC
Gainesville, Florida
Eastlake Cardiovascular, PC
Saint Clair Shores, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.